Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BDMD'
s EV-to-OCF Range Over the Past 10 Years
Min: -118 Med: -31.6 Max: -6.55
Current: -36.19
During the past 5 years, the highest EV-to-OCF of Baird Medical Investment Holdings was -6.55. The lowest was -118.00. And the median was -31.60.
BDMD's EV-to-OCF is ranked better than 91.41% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 7.895
vs BDMD: -36.19
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Baird Medical Investment Holdings (NAS:BDMD) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Baird Medical Investment Holdings's PE Ratio (TTM) for today is calculated as:
Baird Medical Investment Holdings's share price for today is $1.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.518.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Baird Medical Investment Holdings EV-to-OCF Related Terms
Baird Medical Investment Holdings EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings EV-to-OCF Chart
Baird Medical Investment Holdings Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
EV-to-OCF
0.00
0.00
0.00
-33.62
-45.24
Baird Medical Investment Holdings Semi-Annual Data
For the Medical Devices subindustry, Baird Medical Investment Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's EV-to-OCF falls into.
Baird Medical Investment Holdings's current Enterprise Value is $48.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Baird Medical Investment Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-1.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings (BDMD) has a EV-to-OCF of -36.19 as of Sep. 09, 2026. According to the industry distribution chart, Baird Medical Investment Holdings ranks #73 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 8.6%.
Is Baird Medical Investment Holdings' EV-to-OCF too high?
Baird Medical Investment Holdings' current EV-to-OCF is -36.19. Based on the distribution chart, Baird Medical Investment Holdings ranks #73 out of 850 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' EV-to-OCF compare to TANAF and NSYS?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #73 out of 850 companies for EV-to-OCF. This places Baird Medical Investment Holdings in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.90, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baird Medical Investment Holdings's current EV-to-OCF is -36.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current EV-to-OCF of -36.19. The current EV-to-OCF is -36.19. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current EV-to-OCF is -36.19 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
